| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/AJPRENAL.00532.2009 |
| P698 | PubMed publication ID | 20200098 |
| P2093 | author name string | Rujun Gong | |
| David J Morris | |||
| Yan Ge | |||
| Andrew S Brem | |||
| Evelyn Tolbert | |||
| Lance Dworkin | |||
| P2860 | cites work | Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues | Q33888906 |
| THE ACTION OF ALDOSTERONE AND RELATED CORTICOSTEROIDS ON SODIUM TRANSPORT ACROSS THE TOAD BLADDER | Q33954319 | ||
| Plasminogen activator inhibitor-1 and the kidney | Q33960082 | ||
| Infusion of aldosterone, 9-alpha-fluorohydrocortisone and antidiuretic hormone into the renal artery of normal and adrenalectomized, unanesthetized dogs: effect on electrolyte and water excretion. | Q34243823 | ||
| Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner | Q35087985 | ||
| Forestalling fibrosis | Q35600922 | ||
| Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway | Q36598311 | ||
| Aldosterone activates NF-kappaB in the collecting duct. | Q37042182 | ||
| Role of aldosterone in the remnant kidney model in the rat. | Q37358980 | ||
| Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium | Q38624678 | ||
| Co-localization of glucocorticoid metabolizing and prostaglandin synthesizing enzymes in rat kidney and liver | Q39928055 | ||
| Aldosterone receptor occupancy and sodium transport in the urinary bladder of Bufo marinus | Q40175507 | ||
| The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. | Q40806489 | ||
| Effect of aldosterone on renal transforming growth factor-beta | Q44886467 | ||
| 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder | Q45036384 | ||
| Furosemide and the progression of left ventricular dysfunction in experimental heart failure | Q45056655 | ||
| Salt in the wound | Q46178188 | ||
| Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats | Q46314707 | ||
| Glycogen synthase kinase 3beta: a novel marker and modulator of inflammatory injury in chronic renal allograft disease | Q46373640 | ||
| The aggravating mechanisms of aldosterone on kidney fibrosis | Q46542770 | ||
| Regression of existing glomerulosclerosis by inhibition of aldosterone | Q46726706 | ||
| 11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women | Q46929674 | ||
| Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. | Q46956257 | ||
| Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells | Q47618682 | ||
| The Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1 | Q48014590 | ||
| Can renal fibrosis be reversed? | Q52047488 | ||
| Developmental changes in rat renal 11 beta-hydroxysteroid dehydrogenase. | Q52217765 | ||
| Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2. | Q53499338 | ||
| Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium. | Q53607563 | ||
| P433 | issue | 5 | |
| P304 | page(s) | F1178-87 | |
| P577 | publication date | 2010-03-03 | |
| P1433 | published in | American Journal of Physiology - Renal Physiology | Q2610177 |
| P1476 | title | Direct fibrogenic effects of aldosterone on normotensive kidney: an effect modified by 11β-HSD activity | |
| P478 | volume | 298 |
| Q36175955 | A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice. |
| Q58778381 | Activation of mineralocorticoid receptor by ecdysone, an adaptogenic and anabolic ecdysteroid, promotes glomerular injury and proteinuria involving overactive GSK3β pathway signaling |
| Q34257435 | Activation of thiazide-sensitive co-transport by angiotensin II in the cyp1a1-Ren2 hypertensive rat. |
| Q36210088 | Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. |
| Q36688855 | Aldosterone-induced fibrosis in the kidney: questions and controversies |
| Q64126983 | Benidipine reduces ischemia reperfusion-induced systemic oxidative stress through suppression of aldosterone production in mice |
| Q64260873 | Brain natriuretic peptide mitigates TIMP2 induction and reinstates extracellular matrix catabolic activity GSK3β inhibition in glomerular podocytes exposed to a profibrogenic milieu |
| Q44939785 | Chronic hyperaldosteronism in cryptochrome-null mice induces high-salt- and blood pressure-independent kidney damage in mice. |
| Q47603517 | MiR-34c-5p and CaMKII are involved in aldosterone-induced fibrosis in kidney collecting duct cells |
| Q37342099 | Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase αENaC transcription |
| Q101578601 | Role of mineralocorticoid receptor antagonists in kidney diseases |
| Q26996385 | Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease |
Search more.